Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/25720
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahmed, RM | - |
dc.contributor.author | Bocchetta, M | - |
dc.contributor.author | Todd, EG | - |
dc.contributor.author | Tse, NY | - |
dc.contributor.author | Devenney, EM | - |
dc.contributor.author | Tu, S | - |
dc.contributor.author | Caga, J | - |
dc.contributor.author | Hodges, JR | - |
dc.contributor.author | Halliday, GM | - |
dc.contributor.author | Irish, M | - |
dc.contributor.author | Kiernan, MC | - |
dc.contributor.author | Piguet, O | - |
dc.contributor.author | Rohrer, JD | - |
dc.date.accessioned | 2023-01-04T20:52:00Z | - |
dc.date.available | 2021-10-23 | - |
dc.date.available | 2023-01-04T20:52:00Z | - |
dc.date.issued | 2021-10-23 | - |
dc.identifier | ORCID iD: Martina Bocchetta https://orcid.org/0000-0003-1814-5024 | - |
dc.identifier | fcab257 | - |
dc.identifier.citation | Ahmed, R.M. et al. (2021) 'Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach', Brain Communications, 3 (4), fcab257, pp. 1 - 14. doi: 10.1093/braincomms/fcab257. | en_US |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/25720 | - |
dc.description | Supplementary data: Supplementary data is available online at https://academic.oup.com/braincomms/article/3/4/fcab257/6409187#supplementary-data . | en_US |
dc.description.abstract | Copyright © The Author(s) (2021).. The disease syndromes of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) display considerable clinical, genetic and pathological overlap, yet mounting evidence indicates substantial differences in progression and survival. To date, there has been limited examination of how profiles of brain atrophy might differ between clinical phenotypes. Here, we address this longstanding gap in the literature by assessing cortical and subcortical grey and white matter volumes on structural MRI in a large cohort of 209 participants. Cognitive and behavioural changes were assessed using the Addenbrooke’s Cognitive Examination and the Cambridge Behavioural Inventory. Relative to 58 controls, behavioural variant FTD (n = 58) and ALS–FTD (n = 41) patients displayed extensive atrophy of frontoinsular, cingulate, temporal and motor cortices, with marked subcortical atrophy targeting the hippocampus, amygdala, thalamus and striatum, with atrophy further extended to the brainstem, pons and cerebellum in the latter group. At the other end of the spectrum, pure-ALS patients (n = 52) displayed considerable frontoparietal atrophy, including right insular and motor cortices and pons and brainstem regions. Subcortical regions included the bilateral pallidum and putamen, but to a lesser degree than in the ALS–FTD and behavioural variant FTD groups. Across the spectrum the most affected region in all three groups was the insula, and specifically the anterior part (76–90% lower than controls). Direct comparison of the patient groups revealed disproportionate temporal atrophy and widespread subcortical involvement in ALS–FTD relative to pure-ALS. In contrast, pure-ALS displayed significantly greater parietal atrophy. Both behavioural variant FTD and ALS–FTD were characterized by volume decrease in the frontal lobes relative to pure-ALS. The motor cortex and insula emerged as differentiating structures between clinical syndromes, with bilateral motor cortex atrophy more pronounced in ALS–FTD compared with pure-ALS, and greater left motor cortex and insula atrophy relative to behavioural variant FTD. Taking a transdiagnostic approach, we found significant associations between abnormal behaviour and volume loss in a predominantly frontoinsular network involving the amygdala, striatum and thalamus. Our findings demonstrate the presence of distinct atrophy profiles across the ALS–FTD spectrum, with key structures including the motor cortex and insula. Notably, our results point to subcortical involvement in the origin of behavioural disturbances, potentially accounting for the marked phenotypic variability typically observed across the spectrum. | en_US |
dc.description.sponsorship | This work was supported in part by funding to Forefront, a collaborative research group dedicated to the study of FTD and motor neurone disease, from the National Health and Medical Research Council of Australia (NHMRC) program grant (GNT1037746 to O.P., M.C.K. and J.R.H.) and the Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Program (#CE110001021 to O.P. and J.R.H.) and other grants/sources (the National Health and Medical Research Council of Australia project grant GNT1003139 to O.P.), and Royal Australasian College of Physicians, MND Research Institute of Australia. We are grateful to the research participants involved with the ForeFront research studies. R.M.A. is a National Health and Medical Research Council of Australia (NHMRC) Early Career Fellow (#1120770). O.P. is a National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellow (GNT1103258). M.B. is supported by a Fellowship award from the Alzheimer’s Society, UK (AS-JF-19a-004–517). M.B.’s work was also supported by the UK Dementia Research Institute (DRI) which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK. M.I. is supported by an Australian Research Council Future Fellowship (FT160100096). J.D.R. has received funding from an Medical Research Council (MRC) Clinician Scientist fellowship (MR/M008525/1) as well as from the National Institute of Health Research (NIHR) Rare Diseases Translational Research Collaboration (BRC149/NS/MH), the Bluefield Project and the Association for Frontotemporal Degeneration. M.C.K. receives funding from the National Health and Medical Research Council of Australia (NHMRC) Partnership Project (APP1153439) and Practitioner Fellowship (APP1156093) schemes. | en_US |
dc.format.extent | 1 - 14 | - |
dc.format.medium | Electronic | - |
dc.language | English | - |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press on behalf of the Guarantors of Brain | en_US |
dc.rights | Copyright © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject | frontotemporal dementia-amyotrophic lateral sclerosis | en_US |
dc.subject | behavioural | en_US |
dc.subject | cognition | en_US |
dc.subject | imaging | en_US |
dc.title | Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach | en_US |
dc.type | Article | en_US |
dc.identifier.doi | https://doi.org/10.1093/braincomms/fcab257 | - |
dc.relation.isPartOf | Brain Communications | - |
pubs.issue | 4 | - |
pubs.publication-status | Published | - |
pubs.volume | 3 | - |
dc.identifier.eissn | 2632-1297 | - |
dc.rights.holder | The Author(s) | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | 906.38 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License